British Biologicals has grow a long way since 1988 by investing in infrastructure and capabilities in advance of market needs, increased factory capacity, testing methodology, technical support brand marketing, lean manufacturing with USFDA and WHOGMP compliance, which have been key building blocks for the company and its customers long before they were common in the market lace.

British Biologicals is a customer focused organisation dedicated to continuous improvement, uncompromising quality and service second to none.

British Biologicals is now set to pave a new way by launching the CritiCare Division by focusing in the areas of Post Surgical Management primarily for critical ailments like CVD, Renal failure, Burns, ophthalmic Disorders, Oncology, UTI etc.

At CritiCare Division we strive to identify, develop and produce the products available globally, formulate according to patients’ needs.
Therefore, “What is best in the Global Market can be bought from British Biologicals at an affordable price”.

All the products formulated would be effective as an Adjunct Therapy, thereby acting in combination with the primary drugs prescribed for all ailments. The products would serve as a support in the clinical management of the above mentioned ailments.

The products are extensively researched ones with a strong back up of clinical trials, toxicity studies and other relevant studies, which is claimed as best in the Indian Market.